Prostate Cancer (Adenocarcinoma) trials recruiting in Pennsylvania

All Prostate Cancer (Adenocarcinoma) trials nationally

Cities in Pennsylvania

Recruiting trials in Pennsylvania

• A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
  NCT06844383 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · Pennsylvania: Philadelphia
• Adaptive Radiation Therapy for Men With Intermediate- or High-Risk Prostate Cancer
  NCT07219303 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · Pennsylvania: Philadelphia
• Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
  NCT06592924 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · Pennsylvania: Chadds Ford, Danville, Dickson City, Hazleton
• Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
  NCT07745361 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · Pennsylvania: Lancaster